[REGN] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
07-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 37.96%
YoY- 372.80%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 2,048,400 1,933,700 1,711,800 1,927,800 1,663,496 1,608,022 1,511,485 22.44%
PBT 768,500 224,700 546,100 676,200 635,861 656,074 585,398 19.87%
Tax 98,900 31,600 85,000 -144,200 41,206 104,662 107,418 -5.35%
NP 669,600 193,100 461,100 820,400 594,655 551,412 477,980 25.17%
Tax Rate -12.87% -14.06% -15.56% 21.33% -6.48% -15.95% -18.35% -
Total Cost 1,378,800 1,740,600 1,250,700 1,107,400 1,068,841 1,056,610 1,033,505 21.16%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin 32.69 9.99 26.94 42.56 35.75 34.29 31.62 2.24%
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS 6.12 1.77 4.23 7.58 5.51 5.12 4.44 23.83%
EPS Diluted 5.86 1.68 3.99 7.15 5.17 4.82 4.16 25.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.